{{product.productLabel}} {{product.model}}
{{#if product.featureValues}}{{product.productPrice.formattedPrice}} {{#if product.productPrice.priceType === "PRICE_RANGE" }} - {{product.productPrice.formattedPriceMax}} {{/if}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
{{product.productLabel}} {{product.model}}
{{#if product.featureValues}}{{product.productPrice.formattedPrice}} {{#if product.productPrice.priceType === "PRICE_RANGE" }} - {{product.productPrice.formattedPriceMax}} {{/if}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
... The indications & cause of end-stage biventricular heart failure is eliminated by the SynCardia temporary Total Artificial Heart. Both failing ventricles and all four heart valves are replaced by it. The native heart complication is eliminated by the ...
The implantable CH-VAD® left ventricular assist system LVAS is a new generation of totally magnetically levitated VAD. It is inserted in the apex of left ventricle surgically. When blade of rotor rotates, negative pressure is formed in the center of the ...
... CARMAT is a French MedTech that designs, manufactures and markets the Aeson® artificial heart. The Company’s ambition is to make Aeson® the first alternative to a heart transplant, and thus provide a therapeutic solution to people suffering from end-stage ...
... Proven Technology for Right, Left, or Biventricular Support in the Hospital or at Home With more than 30 years of clinical use, the Thoratec PVAD (Paracorporeal Ventricular Assist Device) provides short-to-midterm support in patients of virtually any ...
Thoratec Corporation
... The New Era Begins The HeartMate II is Thoratec’s first-line intermediate-to-chronic left ventricular assist device. Designed to dramatically improve survival and quality of life, the HeartMate II was developed with the goal of providing several ...
Thoratec Corporation